Eli Lilly and Company
AN AURORA A KINASE INHIBITOR FOR USE IN THE TREATMENT OF NEUROBLASTOMA
Last updated:
Abstract:
The present invention provides an inhibitor of Aurora A kinase, Formula (I) illustrated below, or pharmaceutically acceptable salt thereof, for use in treating neuroblastoma. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
22 Nov 2019
Issue date:
6 Jan 2022